Penetrium Bioscience Holds IR Event to Share Pipeline Development and Global Strategy
The event will be held on July 14 and 16, 2026, both online and offline, targeting retail and institutional investors.
Key topics include the development status of the core pipeline Penetrium and the roadmap for global technology licensing.
The IR is hosted by the company itself and does not contain any capital-raising or stock price-related changes.
[AI Summary]This IR is a regular communication event to share drug development progress and business strategy, and does not include new information that directly impacts shareholder value.